Fidelity Investments’s IGM Biosciences IGMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-7,333
| Closed | -$8.21K | – | 5477 |
|
|
2025
Q2 | $8.21K | Buy |
7,333
+1,772
| +32% | +$2.17K | ﹤0.01% | 4585 |
|
|
2025
Q1 | $6.39K | Sell |
5,561
-467,865
| -99% | -$870K | ﹤0.01% | 4636 |
|
|
2024
Q4 | $2.89M | Sell |
473,426
-346,103
| -42% | -$4.11M | ﹤0.01% | 2333 |
|
|
2024
Q3 | $13.6M | Buy |
819,529
+656
| +0.1% | +$7.19K | ﹤0.01% | 1829 |
|
|
2024
Q2 | $5.63M | Sell |
818,873
-498,468
| -38% | -$4.27M | ﹤0.01% | 2048 |
|
|
2024
Q1 | $12.7M | Sell |
1,317,341
-381,165
| -22% | -$4.42M | ﹤0.01% | 1804 |
|
|
2023
Q4 | $14.1M | Sell |
1,698,506
-438,466
| -21% | -$2.55M | ﹤0.01% | 1734 |
|
|
2023
Q3 | $17.8M | Buy |
2,136,972
+1,853
| +0.1% | +$15.7K | ﹤0.01% | 1626 |
|
|
2023
Q2 | $19.7M | Buy |
2,135,119
+1,289,528
| +153% | +$14.4M | ﹤0.01% | 1641 |
|
|
2023
Q1 | $11.6M | Buy |
845,591
+154,633
| +22% | +$3.2M | ﹤0.01% | 1815 |
|
|
2022
Q4 | $11.8M | Buy |
690,958
+690,429
| +130,516% | +$13.8M | ﹤0.01% | 1827 |
|
|
2022
Q3 | $12K | Buy |
529
+222
| +72% | +$4.48K | ﹤0.01% | 4017 |
|
|
2022
Q2 | $5K | Buy |
307
+51
| +20% | +$909 | ﹤0.01% | 4315 |
|
|
2022
Q1 | $7K | Buy |
+256
| New | +$4.77K | ﹤0.01% | 4341 |
|
|
2021
Q4 | – | Sell |
-89,368
| Closed | -$5.88M | – | 4646 |
|
|
2021
Q3 | $5.88M | Sell |
89,368
-10,000
| -10% | -$765K | ﹤0.01% | 2312 |
|
|
2021
Q2 | $8.27M | Sell |
99,368
-22,700
| -19% | -$1.68M | ﹤0.01% | 2182 |
|
|
2021
Q1 | $9.36M | Sell |
122,068
-48,800
| -29% | -$4.44M | ﹤0.01% | 2058 |
|
|
2020
Q4 | $15.1M | Sell |
170,868
-46,260
| -21% | -$3.25M | ﹤0.01% | 1824 |
|
|
2020
Q3 | $16M | Buy |
217,128
+198,311
| +1,054% | +$11.7M | ﹤0.01% | 1659 |
|
|
2020
Q2 | $1.37M | Buy |
18,817
+5,889
| +46% | +$358K | ﹤0.01% | 2350 |
|
|
2020
Q1 | $726K | Hold |
12,928
| – | – | ﹤0.01% | 2381 |
|
|
2019
Q4 | $493K | Buy |
+12,928
| New | +$325K | ﹤0.01% | 2497 |
|
Other funds holding IGMS
Fidelity Investments's IGMS Position: Q3 2025 in Review
Fidelity Investments sold out of IGM Biosciences (IGMS) in Q3 2025, closing a stake of 7,333 shares — an estimated $8.21K sold.
Fidelity Investments first reported a position in IGMS in Q4 2019 and held it in 22 quarters. The position peaked at $19.7M in Q2 2023. 1 fund tracked by Wall St. Rank holds IGMS as of Q3 2025.
- Fidelity Investments reported no remaining IGM Biosciences position as of Q3 2025 after selling out during the quarter.
- Fidelity Investments sold 7,333 IGM Biosciences shares in Q3 2025, an estimated $8.21K.
- Fidelity Investments first reported a position in IGM Biosciences in Q4 2019 and held it in 22 quarters.
- Fidelity Investments's IGM Biosciences position peaked at $19.7M in Q2 2023.
- 1 fund tracked by Wall St. Rank held IGM Biosciences as of Q3 2025.
Based on Fidelity Investments's 13F filing for Q3 2025, filed 13 Nov 2025.